Cambiaggi A, Orengo A M, Meazza R, Sforzini S, Tazzari P L, Lauria F, Raspadori D, Zambello R, Semenzato G, Moretta L, Ferrini S
Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Blood. 1996 Mar 15;87(6):2369-75.
Four patients with lymphoproliferative disease of granular lymphocytes (LDGL) coexpressing CD3 and the natural killer (NK)-related "p58" receptor for HLA-C alleles were studied. These CD3+p58+ LDGLs have been detected among a series of 44 CD3+ LDGLs analyzed. Two patients with LDGL (GI and BA) expressed only the p58 molecule defined by the GL-183 and CH-L monoclonal antibodies (MoAbs), while the cases of patients PU and MA also coexpressed the molecular form identified by EB6 anti-p58 MoAb. Three LDGL cases (GI, MA, and PU) displayed the CD8+4-CD16+ T-cell receptor (TCR)alpha/beta+ phenotype, while one patient (BA) was CD8+4+CD16+ TCRalpha/beta+. Freshly isolated granular lymphocytes (GL) from these cases displayed cytolytic activity in an anti-CD3 MoAb-triggered redirected killing assay against the Fcgamma-receptor+ (Fcgamma-R+) P815 target cell line. Lysis of P815 target cells, triggered by an anti-CD3 or by anti-CD16 MoAb, could be inhibited by the addition of anti-p58 MoAb in three fresh or interleukin (IL)-2-cultured GL tested (GI, MA, and PU). Triggering of cytotoxicity against the HLA-DR+ Fcgamma-R+ Daudi cell line induced by appropriate superantigens could also be inhibited by anti-p58 MoAb in patients PU and GI with LDGL. These data indicate that activation through the CD16, CD3, and TCR molecules can be modulated by p58 receptors in these LDGLs. On the contrary, IL-2-expanded cells of patient BA were induced to lyse P815 target cells by anti-p58 MoAb. In addition, anti-p58 MoAB enhanced anti-CD16 MoAb triggered lysis and did not inhibit activation via CD3. These data indicate that, in this particular patient with LDGL, p58 displays a stimulatory effect on cell triggering, rather than the typical inhibitory effect previously observed in p58+ T-cell clones derived from healthy donors. The anti-p58 MoAb did not induce CA++ mobilization in p58+ LDGLs and in a p58+CD3+ normal T-cell clone equipped with inhibitory p58 molecules, while Ca++ mobilization could be observed in cultured GL from patient BA, which could be activated by anti-58 MoAb. These findings suggest that stimulatory and inhibitory p58 molecules are equipped with different signal transducing properties, thus contributing to a better knowledge of the normal counterpart.
对4例共表达CD3和HLA - C等位基因的自然杀伤(NK)相关“p58”受体的颗粒淋巴细胞增殖性疾病(LDGL)患者进行了研究。在分析的44例CD3 + LDGL中检测到了这些CD3 + p58 + LDGL。2例LDGL患者(GI和BA)仅表达由GL - 183和CH - L单克隆抗体(MoAb)定义的p58分子,而PU和MA患者还共表达了EB6抗p58 MoAb识别的分子形式。3例LDGL病例(GI、MA和PU)表现为CD8 + 4 - CD16 + T细胞受体(TCR)α/β + 表型,而1例患者(BA)为CD8 + 4 + CD16 + TCRα/β + 。从这些病例中新鲜分离的颗粒淋巴细胞(GL)在抗CD3 MoAb触发的针对Fcγ受体 + (Fcγ - R + )P815靶细胞系的重定向杀伤试验中显示出细胞溶解活性。在3例新鲜或经白细胞介素(IL) - 2培养的GL(GI、MA和PU)中测试,抗CD3或抗CD16 MoAb触发的P815靶细胞裂解可被添加抗p58 MoAb抑制。在患有LDGL的PU和GI患者中,抗p58 MoAb也可抑制由适当超抗原诱导的针对HLA - DR + Fcγ - R + Daudi细胞系的细胞毒性触发。这些数据表明,在这些LDGL中,通过CD16、CD3和TCR分子的激活可被p58受体调节。相反,BA患者经IL - 2扩增的细胞被抗p58 MoAb诱导裂解P815靶细胞。此外,抗p58 MoAB增强了抗CD16 MoAb触发的裂解,并且不抑制通过CD3的激活。这些数据表明,在这位患有LDGL的特定患者中,p58对细胞触发显示出刺激作用而不是先前在来自健康供体的p58 + T细胞克隆中观察到的典型抑制作用。抗p58 MoAb在p58 + LDGL和配备抑制性p58分子的p58 + CD3 + 正常T细胞克隆中未诱导Ca ++ 动员,而在患者BA的培养GL中可观察到Ca ++ 动员,其可被抗58 MoAb激活。这些发现表明,刺激性和抑制性p58分子具有不同的信号转导特性,从而有助于更好地了解其正常对应物。